SCWorx Corp receives 180-day extension from Nasdaq to meet minimum bid price requirement, aiming for compliance by April 2026.
Quiver AI Summary
SCWorx Corp, a software-as-a-service company specializing in data management for healthcare providers, has received a 180-day extension from Nasdaq to comply with its minimum bid price requirement, allowing the company until April 6, 2026, to bring its stock price above $1.00. This decision follows SCWorx's initial notification from Nasdaq regarding its failure to meet the requirement on April 10, 2025. During this extension period, if the company maintains a stock price of $1.00 or higher for ten consecutive business days, it will regain compliance. However, if SCWorx fails to meet this requirement, it could face delisting, although it has the option to appeal such a decision. The press release also highlights SCWorx’s innovative data solutions and services aimed at improving operational efficiency for healthcare providers.
Potential Positives
- SCWorx Corp received a 180-day extension from Nasdaq to regain compliance with the minimum bid price requirement, allowing more time to meet the necessary criteria.
- The extension helps maintain the listing status of SCWorx's common stock on the Nasdaq Capital Market, providing reassurance to investors and stakeholders.
- The company has outlined a clear plan to achieve compliance, including the option to implement a reverse stock split if necessary, showing proactive management.
- Nasdaq's determination indicates that SCWorx meets other listing requirements, suggesting that the company is on a stable path despite the bid price issue.
Potential Negatives
- SCWorx Corp has been given a 180-day extension to comply with Nasdaq's minimum bid price requirement, indicating that the company has failed to maintain the required bid price for its stock.
- Failure to meet the minimum bid requirement during the extension could lead to delisting from Nasdaq, which would negatively impact the company's market presence and investor confidence.
- The company may need to implement a reverse stock split to regain compliance, which can further signal financial instability to investors.
FAQ
What is SCWorx Corp's recent Nasdaq notification about?
SCWorx Corp received a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement.
How long does SCWorx have to meet Nasdaq's requirements?
The company has until April 6, 2026, to meet the minimum bid price requirement of $1.00 per share.
What happens if SCWorx does not meet the minimum bid requirement?
If the requirement is not met, Nasdaq may initiate delisting procedures but the company can appeal the decision.
What is the significance of maintaining a $1.00 bid price?
A minimum bid price of $1.00 per share is necessary for continued listing on the Nasdaq Capital Market.
What type of services does SCWorx offer?
SCWorx provides software-as-a-service solutions focused on data management for healthcare providers, including data analytics and contract management.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$WORX Hedge Fund Activity
We have seen 6 institutional investors add shares of $WORX stock to their portfolio, and 4 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CITADEL ADVISORS LLC removed 30,445 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $13,185
- STONEX GROUP INC. added 20,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $8,662
- TWO SIGMA SECURITIES, LLC added 11,849 shares (+inf%) to their portfolio in Q2 2025, for an estimated $5,131
- RENAISSANCE TECHNOLOGIES LLC removed 11,318 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $4,901
- UBS GROUP AG removed 5,264 shares (-74.8%) from their portfolio in Q2 2025, for an estimated $2,279
- CITIGROUP INC added 141 shares (+inf%) to their portfolio in Q2 2025, for an estimated $61
- BANK OF AMERICA CORP /DE/ added 16 shares (+114.3%) to their portfolio in Q2 2025, for an estimated $6
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
Middleton, MA, Oct. 14, 2025 (GLOBE NEWSWIRE) -- SCWorx Corp (Nasdaq: WORX) ("SCWorx" or the "Company"), a software-as-a-service company focused on data management for healthcare providers received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC ("Nasdaq") granting the Company's request for a 180-day extension to regain compliance with Nasdaq's minimum bid price requirement under Nasdaq Listing Rule 5550(a)(2). The Company now has until April 6, 2026 to meet the requirement.
Nasdaq's extension notice has no immediate effect on the continued listing status of the Company's common stock on The Nasdaq Capital Market LLC under the symbol "WORX". If at any time during the additional 180-day extension, the bid price of the Company's common stock closes at, or above, $1.00 per share for a minimum of ten consecutive business days, the Nasdaq staff will provide the Company with a written confirmation of compliance and the matter will be closed.
Nasdaq's determination is based on the Company meeting the continued listing requirement for market value of publicly held shares as well as all other applicable requirements for initial listing on the Capital Market with the exception of the bid price requirement, and the Company's written notice of its intention to cure the deficiency during the second compliance period and if necessary, effecting a reverse stock split.
The Company was first notified by Nasdaq of its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive trading days under Nasdaq Listing Rule 5550(a)(2) on April 10, 2025 and was given until October 7, 2025 to regain compliance.
If the Company does not meet the minimum bid requirement during the additional 180-day extension, Nasdaq will provide written notification to the Company that its common stock will be subject to delisting. At such time, the Company may appeal the delisting determination to a Nasdaq Hearings Panel (the "Panel"). The Company would remain listed pending the Panel's decision. There can be no assurance that if the Company does appeal a subsequent delisting determination, that such appeal would be successful.
About SCWorx Corp.
SCWorx has created an advanced attributed virtualized item data warehouse utilizing machine learning and artificial intelligence to offer a suite of software-as-a-service-based solutions for healthcare providers. The value proposition for customers revolves around the full integration of all solution modules with the company’s data platform for cost savings, operational efficiency and accurate benchmarking and reporting. The solution modules include Virtual Item Master, data cleanse and normalization, contract management and request for pricing (RFP) module, automated rebate management module, data interoperability (EMR, MMIS, finance) module, Automated Item Add Portal, Virtual General Ledger, and the data analytics module. SCWorx creates a single source for information for the healthcare provider’s data governance and analytics requirements.
Forward-Looking Statements
This press release contains “forward-looking statements” that involve substantial risks and uncertainties for purposes of the safe harbor provided by the Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical facts, included in this press release regarding strategy, future operations, future contract renewals and terminations, future financial position, prospects, plans and objectives of management are forward-looking statements. You can identify many (but not all) such forward-looking statements by looking for words such as “assumes,” “approximates,” “believes,” “expects,” “anticipates,” “estimates,” “projects,” “seeks,” “intends,” “plans,” “could,” “would,” “may” or other similar expressions. You should not place undue reliance on these forward-looking statements. Such statements are based on management’s current expectations and involve risks and uncertainties. Actual results and performance could differ materially from those projected in the forward-looking statements as a result of many factors, including, without limitation, economic disruptions affecting our customers, unexpected contract terminations, securing future contracts and orders, future product sourcing, supply disruptions, containing costs, the ability to project future cash utilization and reserves needed for contingent future liabilities and business operations, the availability of sufficient resources of the company to meet its business objectives and operational requirements and other important factors that are detailed in filings with the Securities and Exchange Commission made from time to time by SCWorx, including its Annual Report on Form 10-K for the year ended December 31, 2021, Quarterly Reports on Form 10-Q, and Current Reports on Form 8-K. Matters described in forward-looking statements may also be affected by other known and unknown risks, trends, uncertainties and factors, many of which are beyond the Company’s ability to control or predict. SCWorx undertakes no obligation to release publicly any revisions to any forward-looking statements to reflect events or circumstances after the date hereof or to reflect the occurrence of unanticipated events.
Contacts:
###
Source: SCWorx Corp.